Longevity fund Immortal Dragons invests in stem cell startup Renewal Bio
Immortal Dragons has made a strategic investment in Renewal Bio, an Israeli regenerative medicine company building a patient-matched cell platform. The $40 million purpose-driven longevity fund’s backing supports Renewal Bio’s Stembroid platform, which the company claims produces cells b
<p>Immortal Dragons has made a strategic investment in Renewal Bio, an Israeli regenerative medicine company building a patient-matched cell platform. The $40 million purpose-driven longevity fund’s backing supports Renewal Bio’s Stembroid platform, which the company claims produces cells b</p>